Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122


Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.

Skupien J, Warram JH, Smiles A, Galecki A, Stanton RC, Krolewski AS.

J Am Soc Nephrol. 2014 Dec;25(12):2916-25. doi: 10.1681/ASN.2013091002. Epub 2014 Jun 5.


Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.

Skupien J, Warram JH, Niewczas MA, Gohda T, Malecki M, Mychaleckyj JC, Galecki AT, Krolewski AS.

Diabetes Care. 2014 Sep;37(9):2601-8. doi: 10.2337/dc13-1983. Epub 2014 Jun 4.


The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.

Skupien J, Warram JH, Smiles AM, Niewczas MA, Gohda T, Pezzolesi MG, Cantarovich D, Stanton R, Krolewski AS.

Kidney Int. 2012 Sep;82(5):589-97. doi: 10.1038/ki.2012.189. Epub 2012 May 23.


Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.

Niewczas MA, Mathew AV, Croall S, Byun J, Major M, Sabisetti VS, Smiles A, Bonventre JV, Pennathur S, Krolewski AS.

Diabetes Care. 2017 Mar;40(3):383-390. doi: 10.2337/dc16-0173. Epub 2017 Jan 13.


Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.

Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.

Clin Nephrol. 2013 Oct;80(4):256-62. doi: 10.5414/CN107905.


The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.

De Nicola L, Minutolo R, Chiodini P, Borrelli S, Zoccali C, Postorino M, Iodice C, Nappi F, Fuiano G, Gallo C, Conte G; Italian Society of Nephrology Study Group Target Blood pressure Levels (TABLE) in CKD.

Kidney Int. 2012 Aug;82(4):482-8.


Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.

Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV Jr.

Am J Kidney Dis. 2017 Aug;70(2):191-198. doi: 10.1053/j.ajkd.2016.11.018. Epub 2017 Feb 10.


Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

Am J Kidney Dis. 2000 Jun;35(6):1155-65.


Extreme Levels of HbA1c Increase Incident ESRD Risk in Chinese Patients with Type 2 Diabetes: Competing Risk Analysis in National Cohort of Taiwan Diabetes Study.

Liao LN, Li CI, Liu CS, Huang CC, Lin WY, Chiang JH, Lin CC, Li TC.

PLoS One. 2015 Jun 22;10(6):e0130828. doi: 10.1371/journal.pone.0130828. eCollection 2015.


Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: a prospective observational study.

Joly D, Choukroun G, Combe C, Dussol B, Fauvel JP, Halimi JM, Quéré S, Fiquet B.

Diabetes Res Clin Pract. 2015 Apr;108(1):120-7. doi: 10.1016/j.diabres.2015.01.029. Epub 2015 Feb 12.


Association between magnesium concentration and HbA1c in children and adolescents with type 1 diabetes mellitus.

Galli-Tsinopoulou A, Maggana I, Kyrgios I, Mouzaki K, Grammatikopoulou MG, Stylianou C, Karavanaki K.

J Diabetes. 2014 Jul;6(4):369-77. doi: 10.1111/1753-0407.12118. Epub 2014 Feb 24.


Validation of chronic kidney disease risk categorization system in Chinese patients with kidney disease: A cohort study.

Liu Q, Lv J, Li H, Jiao L, Yang H, Song Y, Xu G.

Nephrology (Carlton). 2015 Dec;20(12):936-44. doi: 10.1111/nep.12528.


Predictors and the Subsequent Risk of End-Stage Renal Disease - Usefulness of 30% Decline in Estimated GFR over 2 Years.

Chang WX, Asakawa S, Toyoki D, Nemoto Y, Morimoto C, Tamura Y, Ota T, Shibata S, Fujigaki Y, Shen ZY, Uchida S.

PLoS One. 2015 Jul 15;10(7):e0132927. doi: 10.1371/journal.pone.0132927. eCollection 2015.


Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.

Trivin C, Metzger M, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E; NephroTest Study Group.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):957-64. doi: 10.2215/CJN.08540814. Epub 2015 May 15.


BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.

Leehey DJ, Zhang JH, Emanuele NV, Whaley-Connell A, Palevsky PM, Reilly RF, Guarino P, Fried LF; VA NEPHRON-D Study Group.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2159-69. doi: 10.2215/CJN.02850315. Epub 2015 Oct 19.


Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes: 10-Year Follow-Up of Taiwan Diabetes Study.

Yang YF, Li TC, Li CI, Liu CS, Lin WY, Yang SY, Chiang JH, Huang CC, Sung FC, Lin CC.

Medicine (Baltimore). 2015 Nov;94(44):e1804. doi: 10.1097/MD.0000000000001804.


Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patients with diabetes.

Tsujimoto Y, Ishimura E, Tahara H, Kakiya R, Koyama H, Emoto M, Shoji T, Inaba M, Kishimoto H, Tabata T, Nishizawa Y.

Ther Apher Dial. 2009 Aug;13(4):358-65. doi: 10.1111/j.1744-9987.2009.00691.x. Epub 2009 May 26.


Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2012 Mar;23(3):516-24. doi: 10.1681/ASN.2011060628. Epub 2012 Jan 19.

Supplemental Content

Support Center